Exosome Research Market is Expected to Reach $356 Million | MarketsandMarkets™

Chicago, Feb. 08, 2024 (GLOBE NEWSWIRE) — Exosome Research market in terms of revenue was estimated to be worth $169 million in 2023 and is poised to reach $356 million by 2028, growing at a CAGR of 16.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Factors like the rising prevalence of cancer, coupled with increased funding in life sciences research and pharmaceutical R&D, have spurred the exosome research market growth. For instance, Thermo Fisher Scientific, Inc. invested USD 1.57 Billion in R&D in 2022. Similarly, QIAGEN invested approx. USD 190 million in R&D in 2022. Additionally, with the growing need for the early diagnosis and effective treatment of life-threatening diseases, there has been an increase in the number of R&D programs aimed at the development of innovative products and technologies. This has ensured steady private investments as well as government funds and grants across the life sciences industry in several fields such as diagnostics, oncology, precision medicine, and biotechnology. This favorable funding scenario for research activities has increased the number of life sciences research projects. This, in turn, is increasing the overall purchase and consumption of exosome products and services.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=224782498

Exosome Research Market Scope:

Report Coverage Details
Market Revenue in 2023 $169 million
Estimated Value by 2028 $356 million
Growth Rate Poised to grow at a CAGR of 16.0%
Market Size Available for 2021–2028
Forecast Period 2023–2028
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product & Service, Indication, Application, Manufacturing Service, and End User
Geographies Covered North America, Europe, Asia Pacific, Rest of World
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Increasing demand for personalized medicine
Key Market Driver Rising cancer prevalence

Based on product & service, the exosome research market is segmented into kits and reagents, instruments, and services. The kits and reagents segment is further categorized as Antibodies, Isolation, Purification, Quantitation Kits and reagents, and Other Kits and reagents. The kits & reagents segment accounted for the largest share of the global exosome research market in 2022. The large share of this segment can primarily be attributed to the increasing demand for liquid biopsy tests, increasing basic research and commercial applications of exosomes, and the need for reliable and specific assays.

Based on application, the global exosome research market is segmented into, tissue regeneration, biomarkers, vaccine development and other applications. In 2022, biomarkers accounted for the largest share of the exosome research market. Biomarkers are important for the early detection of disease and effective therapy, and it is important that these biomarkers are noninvasive, specific, and have high stability. The present lack of such biomarkers has directed the attention of researchers toward exosomes and their content as promising biomarkers.

Based on end users, the exosome research market has been segmented into hospitals & clinical testing laboratories, academic & research institutes and pharmaceutical & biotechnology companies. In 2022, the academics & research institutes segment accounted for the largest share of the exosome research market. The large share of this segment is due to the the growing use of exosomes in cancer and stem cell research, the increasing number of cancer and stem cell research projects across the globe and rising public-private funding for exosome-based research. In 2021, the National Institutes of Health (NIH, US) provided a USD 895,814 grant for five years to fund a project named “Characterization of Keloid Specific Exosomes and Determination of Exosomal Critical Signaling Pathways in the Keloid Microenvironment.”

The key regional markets for the global exosome research market are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the market. The large share of this region is due to the availability of government funding for life sciences research, increasing focus on exosomes in research and diagnostics, favorable regulatory environment, and the presence of high-quality infrastructure for clinical and laboratory research. However, most of the growth in the market is expected from emerging countries across Asia Pacific. During the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the rising disposable income of the middle-class population, infrastructural developments, and rising penetration of cutting-edge diagnostic technologies in Asian countries such as India and China are offering significant growth opportunities for manufacturers and distributors of exosomes.

Buy an Exosome Research Industry Report (238 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=224782498

Exosome Research market major players covered in the report, such as:

  • Thermo Fisher Scientific, Inc. (US)
  • Bio-Techne (US)
  • System Biosciences, LLC (US)
  • QIAGEN (Germany)
  • Lonza (Switzerland)
  • NX Pharmagen (US)
  • NanoSomiX (US)
  • Miltenyi Biotech (Germany)
  • Norgen Biotek Corp. (Canada)
  • AMSBio (UK)
  • Aethlon Medical, Inc. (US)
  • Anjarium Biosciences AG (UK)
  • Ciloa (France)
  • InnovaPrep LLC (US)
  • Creative Medical Technologies Holdings, Inc. (US)
  • ILIAS Biologics, Inc. (South Korea)
  • Unchained Labs (US)
  • Rion, Inc. (US)
  • Cell Guidance System, LLC (UK)
  • INOVIQ (Australia)
  • Danaher Corporation (US)
  • Exopharm (Australia)
  • Everzom (France)
  • RoosterBio, Inc. (US)
  • Creative Biolabs (US)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=224782498

This report categorizes the exosome research market into the following segments:

Exosome research market, by Product & Service

  • Kits & Reagents
    • Antibodies
    • Isolation, Purification, Quantitation Kits, and reagents
    • Other kits & reagents
  • Instruments
  • Services

Exosome research market, by Indication

  • Cancer Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Other Cancers
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Diseases

Exosome Research Market, by Application

  • Biomarkers
  • Vaccine Development
  • Tissue Regeneration
  • Other applications

Exosome research market, by Manufacturing Service

  • Stem cell-derived exosome manufacturing services
  • Dendritic cell-derived exosome manufacturing services
  • Other manufacturing services

Exosome research market, by End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Laboratories

Exosome research market, by region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of Asia Pacific (RoAPAC)
  • Rest of World

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=224782498

Key Market Stakeholders:

  • Exosome research product manufacturers/contract research organizations (CROs)
  • Pharmaceutical and biopharmaceutical companies
  • Academic and research institutes
  • Venture capitalists and investors
  • Market research and consulting firms
  • Government associations
  • Medical institutions and universities

Report Objectives:

  • To define, describe, segment, and forecast the exosome research market by product & service, indication, application, manufacturing service, end-user, and region
  • To provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the market growth
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall exosome research market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the exosome research market in five main regions: North America, Europe, Asia Pacific, Rest of the World, along with their respective key countries
  • To profile the key players in the exosome research market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product & service launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the exosome research market
  • To benchmark players within the exosome research market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

Related Reports:

Stem Cell Therapy Market

Regenerative Medicine Market

Research Antibodies & Reagents Market

Biopsy Devices Market

Breast Biopsy Devices Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/exosome-research-product-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/exosome-research-product.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy